SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-09-058622
Filing Date
2009-12-23
Accepted
2009-12-23 17:47:13
Documents
1
Period of Report
2009-12-17

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c94071_3x0.html 3  
1 MAIN DOCUMENT DESCRIPTION c94071_3x0.xml 3 1593
  Complete submission text file 0001209191-09-058622.txt   3598
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Issuer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 263 CYPRESS ST. BROOKLINE MA 02445
Business Address
Lauterbach Sandra Leigh (Reporting) CIK: 0001479218 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33357 | Film No.: 091259143